Cirrhosis and Gallstones: Risks, Management & Surgery Outcomes

Prevalence and stone type in cirrhosis

Cirrhosis of any etiology (alcoholic, viral, NASH, autoimmune) is associated with a 2‑3 fold increased prevalence of gallstones compared to the general population.

• General population: 10‑15% gallstones.
• Cirrhosis: 20‑40% (up to 50% in advanced Child‑Pugh C).
• Stone type: Predominantly black pigment stones (calcium bilirubinate), unlike the general population where cholesterol stones dominate.
• Gender distribution: In cirrhosis, the female predominance of gallstones is less pronounced; males with cirrhosis have nearly equal risk.

The risk correlates with cirrhosis severity: Child‑Pugh C patients have higher prevalence than Child‑Pugh A/B.

Why cirrhosis promotes gallstones – hemolysis, bile acids, hypomotility

Several factors contribute to lithogenesis in cirrhosis:

• Chronic hemolysis: Hypersplenism and portal hypertension cause splenic sequestration and hemolysis, releasing unconjugated bilirubin. The liver’s reduced conjugating capacity (due to hepatocellular dysfunction) leads to elevated unconjugated bilirubin in bile, which precipitates as calcium bilirubinate (pigment stones).
• Reduced bile acid synthesis and pool: Cirrhotic livers produce fewer primary bile acids. The bile acid pool is depleted relative to cholesterol and bilirubin, promoting crystallisation.
• Gallbladder hypomotility: Cirrhosis impairs gallbladder contraction (possibly due to nitric oxide‑mediated smooth muscle relaxation and autonomic dysfunction). This leads to bile stasis and sludge formation.
• Increased bilirubin load: Even without overt hemolysis, cirrhosis causes ineffective erythropoiesis and increased bilirubin turnover.
• Low albumin: Reduced binding of unconjugated bilirubin increases its free fraction in bile.

Clinical presentation – often silent, but risks of complications

Most cirrhotic patients with gallstones are asymptomatic. However, when symptoms occur, they can be severe:

• Biliary colic: Right upper quadrant pain, often postprandial. However, pain may be less typical due to blunted visceral sensation in cirrhosis.
• Acute cholecystitis: Fever, RUQ tenderness, Murphy’s sign. In cirrhosis, the inflammatory response may be blunted, leading to delayed diagnosis.
• Choledocholithiasis: Stones can migrate into the common bile duct, causing obstructive jaundice and cholangitis. This can be mistaken for worsening liver failure or spontaneous bacterial peritonitis (SBP).
• Gallstone pancreatitis: Less common than in non‑cirrhotic patients, but carries very high mortality.
• Bleeding from gallbladder varices (rare): Portal hypertension can cause varices in the gallbladder wall; cholecystitis or instrumentation may precipitate bleeding.

Diagnosis – ultrasound, portal biliopathy mimics

Abdominal ultrasound is first‑line, but has limitations in cirrhosis:

• Gallstones: Hyperechoic foci with shadowing. Pigment stones may be radiopaque, but ultrasound is sufficient.
• Portal biliopathy: In patients with portal hypertension, dilated collateral veins (cavernous transformation) can compress the bile ducts, mimicking stones or causing cholestasis. MRCP or EUS is needed to differentiate.
• Bile duct stones: MRCP is preferred over ERCP for diagnosis in cirrhotics (avoid invasive procedure if not needed). EUS is also safe and accurate.
• Gallbladder wall abnormalities: Cirrhosis often causes gallbladder wall thickening (from hypoalbuminemia or portal hypertension), which can mimic cholecystitis. Clinical correlation is essential.

If choledocholithiasis is confirmed, ERCP is therapeutic but carries higher risk of bleeding (due to coagulopathy, varices) and encephalopathy. Prophylactic antibiotics and correction of coagulopathy are mandatory.

Non‑surgical management for high‑risk patients

Not every cirrhotic with gallstones needs intervention. Approach depends on symptoms and surgical risk:

• Asymptomatic stones: Observation is safe. Prophylactic cholecystectomy is NOT recommended due to high operative risk.
• Mild biliary colic in Child‑Pugh A/B: Can be managed conservatively (dietary modification, analgesics). Consider elective cholecystectomy if symptoms recur.
• Acute cholecystitis in high‑risk (Child‑Pugh C, MELD >20): Percutaneous cholecystostomy (PC) is preferred over emergency surgery. PC can control sepsis, and the tube can be removed or left long‑term. Delayed cholecystectomy may be considered if liver function improves (e.g., after transplantation).
• Choledocholithiasis with cholangitis: ERCP with sphincterotomy and stone extraction. If bleeding risk is prohibitive (platelets <50, INR >1.5), consider balloon dilation without sphincterotomy, or temporary biliary stenting followed by delayed stone extraction.

Cholecystectomy in cirrhosis – risk stratification (Child‑Pugh, MELD)

Cholecystectomy in cirrhotics carries higher morbidity and mortality than in non‑cirrhotics. Risk is stratified by liver function:

• Child‑Pugh A (well‑compensated): Mortality 1‑3% (vs. <0.5% in non‑cirrhotics). Acceptable risk for elective cholecystectomy if symptomatic.
• Child‑Pugh B (moderate decompensation): Mortality 5‑10%. Surgery should be performed only for severe symptoms or complications. Preoperative optimisation (diuresis, antibiotics, vitamin K) is essential.
• Child‑Pugh C (severe decompensation): Mortality 15‑30%. Elective cholecystectomy is contraindicated. Only emergency surgery for refractory cholecystitis or sepsis after failed percutaneous drainage.

Laparoscopic cholecystectomy is preferred over open (less ascites leak, less wound complications, shorter hospital stay), but conversion rate is higher due to adhesions, varices, and portal hypertension. Subtotal cholecystectomy (leaving the posterior wall) may reduce bleeding risk in difficult cases.

Perioperative considerations – coagulopathy, varices, ascites

Meticulous perioperative management is critical:

• Coagulopathy: Correct INR to <1.5 (fresh frozen plasma, vitamin K). Platelets should be >50,000 (transfuse if lower). Avoid desmopressin unless indicated.
• Portal hypertension / varices: Preoperative endoscopy to band esophageal varices if large. During surgery, avoid tension on the hepatoduodenal ligament and gallbladder bed to prevent variceal bleeding. Use harmonic scalpel or LigaSure for haemostasis.
• Ascites: Drain large volume ascites preoperatively (if tense) to improve surgical exposure and reduce wound complications. Diuretics should be optimised.
• Renal function: Avoid NSAIDs and nephrotoxic agents; maintain hydration to prevent hepatorenal syndrome.
• Encephalopathy: Avoid sedatives; monitor post‑op for decompensation.
• Antibiotic prophylaxis: Cover for spontaneous bacterial peritonitis (SBP) – third‑generation cephalosporin.

Postoperatively, monitor for liver failure, ascites leak, wound infection, and hepatic hydrothorax. Subtotal cholecystectomy leaves a cuff of gallbladder wall; these patients have a higher risk of recurrent stones or mucocele, but this is preferable to massive haemorrhage.

Interactive FAQ – Cirrhosis and gallstones

Disclaimer: This information is for educational purposes. Management of gallstones in cirrhosis is complex and should be undertaken by a multidisciplinary team (hepatology, surgery, interventional radiology). Consult a specialist at Vivekananda Hospital.